Chemoinformaics analysis of (E)-oct-2-enoic acid
Molecular Weight | 142.198 | nRot | 5 |
Heavy Atom Molecular Weight | 128.086 | nRig | 0 |
Exact Molecular Weight | 142.099 | nRing | 0 |
Solubility: LogS | 0.644 | nHRing | 0 |
Solubility: LogP | 0.42 | No. of Aliphatic Rings | 0 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 24.2991 |
nHD | 1 | BPOL | 14.9129 |
QED | 0.552 |
Synth | 2.618 |
Natural Product Likeliness | 0.425 |
NR-PPAR-gamma | 0.002 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.003 |
HIA | 0.001 |
CACO-2 | -4.1 |
MDCK | 0.000448572 |
BBB | 0.55 |
PPB | 0.150207 |
VDSS | 1.189 |
FU | 0.771472 |
CYP1A2-inh | 0.032 |
CYP1A2-sub | 0.62 |
CYP2c19-inh | 0.02 |
CYP2c19-sub | 0.818 |
CYP2c9-inh | 0.004 |
CYP2c9-sub | 0.096 |
CYP2d6-inh | 0.004 |
CYP2d6-sub | 0.141 |
CYP3a4-inh | 0.005 |
CYP3a4-sub | 0.123 |
CL | 6.78 |
T12 | 0.87 |
hERG | 0.082 |
Ames | 0.085 |
ROA | 0.011 |
SkinSen | 0.147 |
Carcinogencity | 0.128 |
EI | 0.974 |
Respiratory | 0.012 |
NR-Aromatase | 0.006 |
Antiviral | No |
Prediction | 0.954314 |